Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Dick (Stuttgart, Germany), S. Wegner (Waiblingen, Germany), T. Wollensak (Stuttgart, Germany), C. Ernst (Stuttgart, Germany). Cost analysis of FeNO for asthma diagnosis in primary care in Germany.. 3151

Member's Comments

No comment yet.

Related content which might interest you: Cost analysis for therapy management of asthmatics with FeNO in primary care in Germany Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 FeNO testing for asthma diagnosis in primary care Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care Year: 2020 The contribution of an asthma diagnostic consultation service (ADCS) in obtaining an accurate asthma diagnosis for primary care patients Source: International Congress 2016 – Asthma management in primary care Year: 2016 Cost of asthma exacerbations managed in primary care in Spain Source: Eur Respir J 2001; 18: Suppl. 33, 329s Year: 2001 Spirometry, FeNO, and asthma control in children managed for asthma in primary care Source: International Congress 2019 – Diagnosis and assessment of airway diseases in primary care Year: 2019 Difference in healthcare resource use among children with asthma who did and did not have allergic rhinitis diagnosis in a UK primary care database Source: Eur Respir J 2002; 20: Suppl. 38, 332s Year: 2002 COPD over diagnosis in the UK Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 Accuracy of COPD diagnosis in primary care in Knowsley, UK Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017 Mapping of COPD guideline adherence in primary care: An observational study in Belgium and Luxembourg Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Medication prescribing for COPD in primary care databases Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Predictors of COPD in high risk individuals seen in primary care Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Identifying undiagnosed COPD through searches of UK routine primary care databases Source: International Congress 2015 – Kaleidoscope of nursing research Year: 2015 Feasibility and acceptability of spirometry and FeNO testing in children treated for asthma in primary care Source: International Congress 2017 – Diagnostic tools in paediatric asthma Year: 2017 Feasibility of using an electronic screening tool for occupational asthma in primary care Source: International Congress 2015 – Occupational and environmental cohort investigations and population studies Year: 2015 Association between chronic comorbidity and exacerbation rate in primary care COPD patients. Preliminary analysis of real-life general practice data (PROSPECT1) Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016 Spirometry interpretation for primary care: A validation study Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013 Comparison among three screening questionnaires for COPD diagnosis in the primary care Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 Costs of asthma care in Belgium Source: Eur Respir J 2001; 18: Suppl. 33, 441s Year: 2001 Over-diagnosis of COPD in UK primary care Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences Year: 2012 Application of the COMCOLD comorbidity index to a UK primary care COPD cohort Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015